R. Vrabec

发表

Plasma homocysteine is associated with nonproliferative retinopathy in patients with type 2 diabetes without renal disease.

D. Rahelić, T. Bulum, S. Ljubic, 2021, Diabetes & metabolic syndrome.

Hypertension and Hypercholesterolemia are Associated with Cataract Development in Patients with Type 2 Diabetes

D. Rahelić, T. Bulum, S. Ljubic, 2021, High Blood Pressure & Cardiovascular Prevention.

HDL cholesterol is a protective predictor in the development and progression of retinopathy in type 1 diabetes: a 15-year follow-up study.

T. Bulum, S. Ljubic, M. Tomić, 2022, Diabetes research and clinical practice.

Ocular findings in patients with chronic renal failure undergoing haemodialysis.

D. Pavlović, Z. Vatavuk, K. Bućan, 2005, Collegium antropologicum.

Diabetic Macular Edema: Traditional and Novel Treatment

L. Duvnjak, S. Ljubic, M. Tomić, 2017, Acta clinica Croatica.

Systemic inflammation and dyslipidemia are associated with retinopathy in type 2 but not in type 1 diabetes

T. Bulum, S. Ljubic, M. Tomić, 2020, Scandinavian journal of clinical and laboratory investigation.

BLOOD PRESSURE IS ASSOCIATED  WITH DIABETIC RETINOPATHY  IN TYPE 1 BUT NOT IN TYPE 2 DIABETES

T. Bulum, I. Prkačin, S. Ljubic, 2022, Acta clinica Croatica.

Analysis of Current Ophthalmology Residency Curriculum

Z. Vatavuk, G. Bencic, Z. Mandić, 2007 .

Systolic and Diastolic Blood Pressure Are Independent Risk Factors for Diabetic Retinopathy in Patients with Type 2 Diabetes

T. Bulum, S. Ljubic, M. Tomić, 2023, Biomedicines.

Patients with Type 2 Diabetes, Higher Blood Pressure, and Infrequent Fundus Examinations Have a Higher Risk of Sight-Threatening Retinopathy

T. Bulum, S. Ljubic, M. Tomić, 2024, Journal of clinical medicine.